OncoLink Editorial Board

Last Modified: April 15, 2016

Executive Director
James Metz, MD

Editor-in-Chief
Christine Hill-Kayser, MD

Senior Editor
Neha Vapiwala, MD

Director of Strategic Partnerships
Maggie Hampshire, RN, BSN, OCN

Managing Editor
Carolyn Vachani, MSN, RN, AOCN

Oncology Content Specialist
Karen Arnold-Korzeniowski, BSN, RN

Psychosocial Oncology Content Editor
Christina Bach, MBE, MSW, LCSW, OSW-C

Staff Writers
Brian Baumann, MD

David Guttmnan, MD

Eric Ojerholm, MD

Production Staff
JoMarie Hoholik, Project Manager, Beaconfire RED
David Sayre, Technology Lead and Senior Developer, Beaconfire RED

Poet-in-Residence
Alysa Cummings

Medical Translator
Evelyn Robles-Rodriguez, RN, MSN, APN, AOCN

Abramson Cancer Center of the University of Pennsylvania Advisors
Chi Van Dang, MD, PhD, Director, Abramson Cancer Center

Philip Okala, Senior Vice President Business Development, Penn Medicine

Founding Editor
Joel W. Goldwein, MD

OncoLink Editorial Policy
All materials created by OncoLink are educational and non-promotional in nature and are prepared, designed and executed in accordance with the U.S. Food and Drug Administration Guidance on Industry-Supported Scientific and Educational Activities ("Policy Statement"). The OncoLink Editorial Staff creates this content independently and without control or influence by our sponsors over the materials. We are committed to educating the public while keeping our content free of commercial bias for or against any product; our sponsors may not require OncoLink or the Abramson Cancer Center of the University of Pennsylvania to accept advice or services concerning speakers, authors, participants or other education matters, including content; OncoLink will make meaningful disclosure of each sponsor’s support of the program with banner and text placements as appropriate. Likewise, our licensees will make meaningful disclosure of OncoLink’s authorship with banner or text placements as appropriate. The OncoLink Editorial Team will ensure that any product discussions in the content will be objective, balanced and scientifically rigorous. This includes a balanced discussion of the product and of treatment alternatives, limitations on data will be disclosed, and unapproved uses will be identified as such. All funding will be used for educational content creation purposes only.

Blogs

This Thing Called the Internet and the World Wide Web
by Carolyn Vachani, MSN, RN, AOCN
March 12, 2012

OncoLink Celebrates 20 Years of Helping Millions!
by Carolyn Vachani, MSN, RN, AOCN
April 9, 2014

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
R
S
T
U
V
X
Y
Z
#
 
A
B
C
E
F
G
H
K
L
M
N
O
P
R
S
T
U
V
 
 
Want up to date Cancer Treatment News? Subscribe to our eNewsletter. Subscribe Now